Search results for "Adverse effect"

showing 10 items of 1065 documents

Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers

2015

Introduction: The TONADO studies (NCT01431274; NCT01431287) established the efficacy and safety of a new once-daily fixed-dose combination (FDC) with tiotropium (T), a long-acting muscarinic antagonist, and olodaterol (O), a long-acting β 2 -agonist, for the treatment of COPD. This post hoc analysis evaluates T+O safety in the subgroup of patients (pts) receiving β-blockers (BBs) in these studies. Methods: These were randomised, double-blind, parallel-group, 52-week, Phase III trials comparing T+O FDC (2.5/5 µg; 5/5 µg) with the monocomponents. Adverse events (AEs) and serious AEs (SAEs) were recorded and SAEs independently adjudicated. Pooled safety data from pts receiving BBs at baseline …

congenital hereditary and neonatal diseases and abnormalitiesCOPDmedicine.medical_specialtybusiness.industryIncidence (epidemiology)Fixed-dose combinationOlodaterolMuscarinic antagonistmedicine.diseasechemistry.chemical_compoundchemistryInternal medicinePost-hoc analysisMedicineIn patientbusinessAdverse effectmedicine.drug5.1 Airway Pharmacology and Treatment
researchProduct

Results of a Prospective, Open-Label Trial to Assess the Efficacy, Safety and Immunogenicity of Wilate® in Children Under 6 Years of Age with Inherit…

2011

Abstract Abstract 3330 Introduction: Wilate® is a new-generation plasma-derived concentrate of von Willebrand factor (VWF) and factor VIII (FVIII) developed for treatment of patients with von Willebrand disease (VWD) and haemophilia A. The objective of this study was to assess efficacy, safety and immunogenicity of Wilate in children below 6 years of age with inherited VWD. Methods: The prospective, multi-centre trial included patients with inherited VWD of any type below 6 years of age with insufficient response to DDAVP. Any clinical event requiring VWF/FVIII concentrate treatment within 1 year was treated with Wilate. Efficacy was recorded by using a 4-point VRS and in vivo recovery of F…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsbiologybusiness.operationbusiness.industryImmunogenicityImmunologyCell BiologyHematologyHaemophiliamedicine.diseaseOctapharmaBiochemistryVon Willebrand factorTolerabilityhemic and lymphatic diseasesInternal medicinemedicinebiology.proteinVon Willebrand diseaseDosingbusinessAdverse effectBlood
researchProduct

Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey

2022

Abstract We investigated menstrual irregularities after the first and second doses of the COVID-19 vaccine. Women answered a customised online questionnaire (ClinicalTrial.gov ID: NCT05083065) aimed to assess the vaccine type, the phase of the menstrual cycle during which the vaccine was administered, the occurrence of menstrual irregularities after the first and second doses, and how long this effect lasted. We excluded women with gynaecological and non-gynaecological diseases, undergoing hormonal and non-hormonal treatments, in perimenopause or menopause, as well as those who had irregular menstrual cycles in the last 12 months before vaccine administration. According to our data analysis…

covid19mestrual irregularitymenstrual irregularitiesadverse effectvaccineabnormal uterine bleedingCOVID-19General MedicineMenstrual irregularitieabnormal uterine bleeding; adverse effect; COVID-19; menstrual irregularities; vaccine
researchProduct

Environment and Endometriosis: A toxic relationship

2015

Endometriosis is a common, be- nign, estrogen-dependent gynecological dis- ease that represents one of the main causes of hospitalization in industrialized countries. It is well established that a large amount of natural and man-made chemicals are present in the en- vironment and both humans and animals are exposed to them. Dioxin and dioxin-like com- pounds have long biological half-life, can accu- mulate within the organism and could negative- ly affect several physiological processes. The purpose of this review is to provide an overview of the possible relationship between these chemicals and the pathogenesis of en- dometriosis.

ddc:616DioxinPolychlorinated Biphenyls/toxicityddc:618Endometriosis Environment Dioxin Dioxin-like compounds.Endometriosisanimals; dioxins; endometriosis; environmental exposure; female; humans; polychlorinated biphenylsEnvironmental ExposureEnvironmentDioxinsPolychlorinated BiphenylsSettore MED/40 - Ginecologia E OstetriciaEndometriosis/etiology/pathologyNODioxin-like compoundsAnimalsHumansFemaleDioxins/toxicityEnvironmental Exposure/adverse effectsDioxin; Dioxin-like compounds; Endometriosis; Environment
researchProduct

Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia …

2020

The growing insights in the next-generation immunotherapy and the state-of-the-art advancement in targeted-agents significantly improved clinical outcome of cancer patients by pointing towards a unexplored Achilles' heel. Novel toxicity profiles have been uncovered, representing unmet medical needs. Thus, a panel of expert provide comprehensive pharmacological and clinical evidence, to provide a patient-tailored approach to metabolic adverse events associated with novel anti-cancer treatments. Prompted by the need of a multidisciplinary cooperation, a working group of Associazione Italiana Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD) and Societa Italiana Farmacologia (SIF)…

diabetes; dyslipidemia; hypercholesterolemia; hyperglycemia; hypertriglyceridemia; immunotherapy; metabolic effect; targeted therapy; Consensus; Humans; Immunologic Factors; Italy; Medical Oncology; Neoplasms; Physicians0301 basic medicinemedicine.medical_specialtyConsensusSettore MED/06 - Oncologia MedicaImmune checkpoint inhibitorsmedicine.medical_treatmentPatient riskhypertriglyceridemiaMedical OncologyTargeted therapy03 medical and health sciences0302 clinical medicineMultidisciplinary approachNeoplasmsPhysiciansmedicineHumansImmunologic FactorsIntensive care medicineAdverse effectdiabeteshypercholesterolemiabusiness.industrydyslipidemiametabolic effectHematologytargeted therapy030104 developmental biologyOncologyItalyClinical evidence030220 oncology & carcinogenesisMetabolic effectsPosition paperhyperglycemiaimmunotherapybusiness
researchProduct

Polytetrafluoroethylene Films in Rigid Polyurethane Foams' Dielectric Permittivity Measurements with a One-Side Access Capacitive Sensor.

2021

As a non-metallic composite material, widely applied in industry, rigid polyurethane (PUR) foams require knowledge of their dielectric properties. In experimental determination of PUR foams’ dielectric properties protection of one-side capacitive sensor’s active area from adverse effects caused by the PUR foams’ test objects has to be ensured. In the given study, the impact of polytetrafluoroethylene (PTFE) films, thickness 0.20 mm and 0.04 mm, in covering or simulated coating the active area of one-side access capacitive sensor’ electrodes on the experimentally determined true dielectric permittivity spectra of rigid PUR foams is estimated. Penetration depth of the low frequency excitation…

dielectric permittivityMaterials sciencePolymers and PlasticsCapacitive sensing02 engineering and technologyDielectricengineering.materialLow frequency01 natural sciencesArticlelcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistryCoatingone-side access0103 physical sciencesComposite materialPenetration depthPolyurethane010302 applied physicsPolytetrafluoroethylenepolyurethane foamscapacitive sensorGeneral Chemistryprotectionpolyurethane foams; dielectric permittivity; capacitive sensor; one-side access; adverse effects; protection; PTFE films021001 nanoscience & nanotechnologychemistryPTFE filmsElectrodeadverse effectsengineering0210 nano-technologyPolymers
researchProduct

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C

1997

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.3% with cirrhosis, 80.6% with HCV type 1) received interferon alfa-2b for 26 weeks (10 MU tiw for 8 weeks, then 5 MU tiw for 18 weeks). One hundred and twenty-four subjects (40%) normalized aminotransferases, and were allocated randomly either to continue on 5 MU tiw for a further 26 weeks (prolonged therapy group: 60 patients) or to stop interferon (brief therapy group: 64 patients). Fifty-two w…

education.field_of_studyChemotherapyCirrhosisbusiness.industryHepatitis C virusmedicine.medical_treatmentPopulationAlpha interferonmedicine.disease_causemedicine.diseaseVirologyInfectious DiseasesMaintenance therapyVirologymedicineAdverse effectbusinesseducationInterferon alfamedicine.drugJournal of Medical Virology
researchProduct

Exercise effects on cardiovascular disease: from basic aspects to clinical evidence.

2021

Contains fulltext : 283453.pdf (Publisher’s version ) (Closed access) Cardiovascular (CV) disease (CVD) remains the leading cause of major morbidity and CVD- and all-cause mortality in most of the world. It is now clear that regular physical activity (PA) and exercise training (ET) induces a wide range of direct and indirect physiologic adaptations and pleiotropic benefits for human general and CV health. Generally, higher levels of PA, ET, and cardiorespiratory fitness (CRF) are correlated with reduced risk of CVD, including myocardial infarction, CVD-related death, and all-cause mortality. Although exact details regarding the ideal doses of ET, including resistance and, especially, aerobi…

education.field_of_studymedicine.medical_specialtyPhysiologybusiness.industryPopulationVascular damage Radboud Institute for Health Sciences [Radboudumc 16]Cardiorespiratory fitnessDiseasemedicine.diseaseCardiorespiratory FitnessEndurance trainingClinical evidenceCardiovascular DiseasesRisk FactorsPhysiology (medical)medicineHumansMyocardial infarctionCardiology and Cardiovascular MedicineeducationPhysiologic AdaptationsAdverse effectIntensive care medicinebusinessExerciseCardiovascular Research
researchProduct

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials

2019

The role of nutrition in mental health is becoming increasingly acknowledged. Along with dietary intake, nutrition can also be obtained from "nutrient supplements", such as polyunsaturated fatty acids (PUFAs), vitamins, minerals, antioxidants, amino acids and pre/probiotic supplements. Recently, a large number of meta-analyses have emerged examining nutrient supplements in the treatment of mental disorders. To produce a meta-review of this top-tier evidence, we identified, synthesized and appraised all meta-analyses of randomized controlled trials (RCTs) reporting on the efficacy and safety of nutrient supplements in common and severe mental disorders. Our systematic search identified 33 me…

eicosapentaenoic acidNutrient supplements polyunsaturated fatty acids omega-3 eicosapentaenoic acid methylfolate vitamin D N-acetylcysteine depression schizophrenia attention-deficit/hyperactivity disorder adjunctive treatmentvitamin Dlaw.invention0302 clinical medicineRandomized controlled triallawL-METHYLFOLATEVITAMIN-D SUPPLEMENTATIONOXIDATIVE STRESSPsychiatryMAJOR DEPRESSIVE DISORDERPOLYUNSATURATED FATTY-ACIDSattention-deficitGUT MICROBIOTAPsychiatry and Mental healthNutrient supplementsCARDIOVASCULAR-DISEASESchizophreniadepressionhyperactivity disorderMajor depressive disorderomega-3Pshychiatric Mental HealthLife Sciences & Biomedicinepolyunsaturated fatty acidsmedicine.medical_specialtyDEFICIT HYPERACTIVITY DISORDERattention-deficit/hyperactivity disorder03 medical and health sciencesmedicineAttention deficit hyperactivity disorderPsychiatryAdverse effectIntensive care medicineScience & Technologybusiness.industrymethylfolateadjunctive treatmentResearch Reportsmedicine.diseaseNUTRITIONAL MEDICINEMental healthN-acetylcysteine030227 psychiatryschizophreniaMood disordersAdjunctive treatmentbusiness030217 neurology & neurosurgeryWorld Psychiatry
researchProduct

Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study

2012

A previous US study reported poorer survival in children with acute lymphoblastic leukemia (ALL) exposed to extremely low-frequency magnetic fields (ELF–MF) above 0.3 μT, but based on small numbers. Data from 3073 cases of childhood ALL were pooled from prospective studies conducted in Canada, Denmark, Germany, Japan, UK and US to determine death or relapse up to 10 years from diagnosis. Adjusting for known prognostic factors, we calculated hazard ratios (HRs) and 95% confidence intervals (CI) for overall survival and event-free survival for ELF–MF exposure categories and by 0.1 μT increases. The HRs by 0.1 μT increases were 1.00 (CI, 0.93–1.07) for event-free survival analysis and 1.04 (CI…

electromagnetic fieldsPediatricsmedicine.medical_specialtybusiness.industryLymphoblastic LeukemiaHazard ratioleukemiaFollow up studiesHematologysurvivalConfidence intervalchildrenOncologyInternal medicineadverse effectsmedicineOriginal ArticlebusinessProspective cohort studyChildhood allChildhood Acute Lymphoblastic LeukemiaSurvival analysispooled analysesBlood Cancer Journal
researchProduct